SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Trine Zeeberg Iversen, Marie Klinge Brimnes, Kirsten Nikolajsen, Rikke Sick Andersen, Sine Reker Hadrup, Mads Hald Andersen, Lars Bastholt, Inge Marie Svane, Depletion of T lymphocytes is correlated with response to temozolomide in melanoma patients, OncoImmunology, 2013, 2, 2, e23288

    CrossRef

  2. 2
    Marieke IG Raaijmakers, Sima Rozati, Simone M Goldinger, Daniel S Widmer, Reinhard Dummer, Mitchell P Levesque, Melanoma immunotherapy: historical precedents, recent successes and future prospects, Immunotherapy, 2013, 5, 2, 169

    CrossRef

  3. 3
    Tyler J. Curiel, Immunotherapy: A useful strategy to help combat multidrug resistance, Drug Resistance Updates, 2012, 15, 1-2, 106

    CrossRef

  4. 4
    Donald N. Liew, Hideyuki Kano, Douglas Kondziolka, David Mathieu, Ajay Niranjan, John C. Flickinger, John M. Kirkwood, Ahmad Tarhini, Stergios Moschos, L. Dade Lunsford, Outcome predictors of Gamma Knife surgery for melanoma brain metastases, Journal of Neurosurgery, 2011, 114, 3, 769

    CrossRef

  5. 5
    Lucio Tentori, Annalisa Susanna Dorio, Emanuela Mazzon, Alessia Muzi, Andrea Sau, Salvatore Cuzzocrea, Patrizia Vernole, Giorgio Federici, Anna Maria Caccuri, Grazia Graziani, The glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanoma, European Journal of Cancer, 2011, 47, 8, 1219

    CrossRef

  6. 6
    Susan J. Lee, Javier Chinen, Arthur Kavanaugh, Immunomodulator therapy: Monoclonal antibodies, fusion proteins, cytokines, and immunoglobulins, Journal of Allergy and Clinical Immunology, 2010, 125, 2, S314

    CrossRef

  7. 7
    Aaron S Mansfield, Svetomir N Markovic, Novel therapeutics for the treatment of metastatic melanoma, Future Oncology, 2009, 5, 4, 543

    CrossRef